The FDA’s data on chemical abortions is encountering fresh scrutiny from authors alleging that significant discrepancies have occurred in previous figures.The FDA’s data on chemical abortions is encountering fresh scrutiny from authors alleging that significant discrepancies have occurred in previous figures.
Sala: “Il passo indietro sul Salva-Milano non è una resa. Politica divisa, ma serve una legge”
Marzo 7, 2025
Read More Seguici su: 2 minuti di lettura Supplementi Repubblica Affari e Finanza D Il Venerdì Robinson Gedi News Network La Stampa HuffPost Italia Fem
